EMA — authorised 18 September 2015
- Marketing authorisation holder: MERCK SHARP & DOHME B.V.
- Status: approved
EMA authorised Zosyn on 18 September 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 18 September 2015.
MERCK SHARP & DOHME B.V. holds the EU marketing authorisation.